t-cells

Documents about t-cells

• GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)#181750ClinicalTrials.gov
• Whole-protein screening and multi-modal profiling of antigen-specific CD4(+) T cells at single-cell resolution.#182401NCBI PubMed Central
• Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells#190314Ora Oxford University Research
• Interplay between microRNAs and TGF-β signaling in T cells: implications for Th9 differentiation and immune pathogenesis.#199150NCBI PubMed Central
• Assessment of mitochondrial ferroptosis in cells and in vivo using a targeted mass spectrometry lipid peroxidation probe#205323Enlighten Research Data
• Pea plants conditionally sanction less effectively fixing rhizobia at the level of whole nodules rather than single cells#211638Ora Oxford University Research
• Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma#252986ClinicalTrials.gov
• T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells#264891IRIS
• Identification of alterations of immunometabolism associated with Pompe disease#268658HAL (France)
• CXCL13-expressing CD4(+) T cells coordinate the lymphocytes triad to promote the anti-tumor immunity in NSCLC.#285112NCBI PubMed Central
• T cells: Bridge-and-channel commute to the white pulp#301329ISTA Publications
• IL-2 mutein promotes antigen-specific transplant acceptance in mice through expansion of ST2(+) regulatory T cells.#308791NCBI PubMed Central
• Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies#353289ClinicalTrials.gov
• Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer#356464ClinicalTrials.gov
• Superantigen-driven polyfunctional CD4+ T follicular regulatory cells impair tonsillar plasmablast function and class-switched antibody production#374143Europe PMC
• A soluble bi-specific fusion protein for the improved expansion of human CD8+ CAR-T cells#379857bioRxiv / medRxiv
• alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells#383553ClinicalTrials.gov
• Blautia coccoides-derived acetate potentiates anti-PD-1 immunotherapy in melanoma by activating cytotoxic CD8(+) T cells.#388842NCBI PubMed Central
• Non-redundant functions of NFATc1 in survival and NFATc2 in generation of exhausted CD8(+) T cells.#439102NCBI PubMed Central
• Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma#451461ClinicalTrials.gov
• Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma#481760ClinicalTrials.gov
• DC1s-CTL Cellular Therapy for Renal Cell Carcinoma#811358ClinicalTrials.gov
• Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma#859876ClinicalTrials.gov
• CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma#877348ClinicalTrials.gov
• huCART19-IL18 in CD19+ Cancers#880694ClinicalTrials.gov
• γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors#994692ClinicalTrials.gov
• Longitudinal analysis of invariant natural killer T cell activation reveals a cMAF-associated transcriptional state of NKT10 cells#1005372The University of Melbourne Library Digital Repository
• Cellular immune signatures of clinical outcome in hepatitis C virus infection#1005594The University of Melbourne Library Digital Repository
• HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors#1033516ClinicalTrials.gov
• Bronchoalveolar lavage (BAL) in patients with Post-COVID-19 Syndrome (PCS). Flow cytometry and ELISA#206713RepOD Dataverse OAI Archive
• P-MAPA activates TLR2 and TLR4 signaling while its combination with IL-12 stimulates CD4+ and CD8+ effector T cells in ovarian cancer#255720Repositório Institucional Unesp
• Unleashing anti-tumour immunity: Dietary restriction and exercise interventions adjunct to chemotherapy for cancer patients#277533Research Online
• CD39, nouvelle cible thérapeutique dans les lymphomes non Hodgkiniens - mythe ou réalité ?#226839HAL (France)
• CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL#889283ClinicalTrials.gov
• Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma#892263ClinicalTrials.gov
• CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia#912585ClinicalTrials.gov
• Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM#1010948ClinicalTrials.gov
• Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient#830824ClinicalTrials.gov
• Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions#915398ClinicalTrials.gov
• Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection#28300ClinicalTrials.gov
• Clathrin-independent endocytosis and retrograde transport in cancer cells tune immune synapse organization and CD8 T cell response.#125347NCBI PubMed Central
• E7 TCR T Cells for Human Papillomavirus-Associated Cancers#148590ClinicalTrials.gov
• Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?#152412ClinicalTrials.gov
• IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8(+) T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.#174624NCBI PubMed Central
• OCA-B/Pou2af1 Expression in T Cells Promotes PD-1 Blockade-Induced Autoimmunity but is Dispensable for Anti-Tumor Immunity#189362bioRxiv / medRxiv
• Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Depending on Tumor Characteristics#208430ClinicalTrials.gov
• Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery#245522ClinicalTrials.gov
• High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells#284299HAL (France)
• Immunogenetic investigation of WAS patients revealing impaired IL-6/STAT3 signaling in T cells#322618HAL (France)
• Translational control shapes the suppressive output of tumour-infiltrating regulatory T cells by coupling metabolism to protein synthesis#387694Europe PMC